Focused Wealth Management, Inc Novavax Inc Transaction History

Focused Wealth Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 10, 2024	SELL	$4.8 - $7.67 $1,564 - $2,500	-326 Reduced 90.81%	33 $0
Q3 2023 Nov 01, 2023	SELL	$6.81 - $9.74 $1,906 - $2,727	-280 Reduced 43.82%	359 $2,000
Q2 2022 Aug 04, 2022	BUY	$36.28 - $75.29 $1,197 - $2,484	33 Added 5.45%	639 $33,000
Q1 2022 Apr 29, 2022	BUY	$69.73 - $142.9 $42,256 - $86,597	606 New	606 $45,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Focused Wealth Management, Inc with notifications on news.